Hutch News

Hutch News

Stories tagged 'Frederick R Appelbaum'

The legacy of a pioneering transplant immunologist

‘So much to be learned’: Dr. John Hansen reflects on the lives he’s saved and the answers still to come

July 11, 2018 | by Susan Keown / Fred Hutch News Service

Among his many contributions to bone marrow transplantation, Hansen helped define the rules for matching donors and patients and was a founding father of volunteer donor registries.

View story >


3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant

$20M renewal of 4-decade-long federal grant to Hutch scientists

May 31, 2018 | By Susan Keown / Fred Hutch News Service

The National Cancer Institute has awarded Hutch with five years and nearly $20 million in funding for research to develop better therapies for people with blood cancers. The award is the latest renewal of a grant that has been funded continuously for more than 40 years.

View story >


Remembering Shan Mullin

Former Fred Hutch, SCCA board chair was 'a rock of wisdom and stability' during pivotal times

Feb. 23, 2018 | By Mary Engel / Fred Hutch News Service

The former long-time member and chair of the Fred Hutch Board of Trustees, Shan Mullin was 'a rock of wisdom and stability' during pivotal times that included the founding of Seattle Cancer Care Alliance.

View story >


Dr. Paul Neiman, founding member of Fred Hutch, dies at 78

Physician-scientist led the charge in prioritizing fundamental research, built bridges between lab and clinic

Oct. 12, 2017 | By Rachel Tompa / Fred Hutch News Service

Dr. Paul Neiman, a founding member of Fred Hutchinson Cancer Research Center and a transplant physician and cancer biologist, died Oct. 11 of complications from pancreatic cancer. He was 78. Neiman was also one of the founders and leaders of the Basic Sciences Division, one of the Hutch’s five scientific divisions, as well as the division that would later became the Human Biology Division. He served as director of Basic Sciences from 1983 to 1995. He retired from Fred Hutch in 2010.

View story >


Bringing a leukemia treatment back to life with precision medicine

New research writes latest chapter in one drug's story

June 27, 2017 | by Susan Keown / Fred Hutch News Service

The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 22, 2016

For fourth year in a row, Fred Hutch/SCCA transplant rates among best in the U.S.; immuntherapy symposium available on video for those who couldn't attend the event

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.